NCT06280898

Brief Summary

Divided into two groups based on acute kidney injury: non-acute kidney injury group vs. non-acute kidney injury group. Acute kidney injury group, Acute Kidney Injury Network (AKIN), Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease (RIFLE), or Kidney Disease: Improving Global Outcomes (KDIGO) I would like to divide it according to the definition. After testing the normal distribution of patients, donors, grafts, types of immunosuppressants, surgery/anesthesia factors, and blood test findings between the two groups through the Shapiro-Wilk test, continuous data was tested using the student t-test or Mann-Whitney U test. Sizes are compared using , and categorical data is compared with proportions using the χ2 test or Fisher's exact test. Analysis of factors related to acute kidney injury will be performed through univariate and multivariate logistic regression analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
539

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2022

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

February 16, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 28, 2024

Completed
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

1.9 years

First QC Date

February 16, 2024

Last Update Submit

February 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Troponin I

    Troponin I difference in two groups

    up to 24 hour postoperatively

Secondary Outcomes (2)

  • Troponin T

    up to 24 hour postoperatively

  • QTc interval

    up to 24 hour postoperatively

Study Arms (2)

nonischemic

ischemic

Procedure: Remote ischemic conditioning

Interventions

Remote ischemic condition

ischemic

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients aged 19 or older who underwent kidney transplant surgery in the operating room of Seoul St. Mary's Hospital from January 1, 2016 to March 28, 2022.

You may qualify if:

  • Adult patients aged 19 years or older who underwent kidney transplant surgery in the operating room

You may not qualify if:

  • Pediatric patients under 19 years of age
  • Patients with multiple organ transplants, including kidney transplants
  • Patients undergoing re-kidney transplant surgery
  • Patient examination findings missing from electronic medical record

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul St. Mary's hospital

Seoul, 06591, South Korea

Location

MeSH Terms

Conditions

Heart Injuries

Condition Hierarchy (Ancestors)

Thoracic InjuriesWounds and Injuries

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 16, 2024

First Posted

February 28, 2024

Study Start

May 1, 2020

Primary Completion

March 14, 2022

Study Completion

March 14, 2022

Last Updated

February 29, 2024

Record last verified: 2024-02

Locations